BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29146641)

  • 21. Consumption of Whole-Grain Bread and Risk of Colorectal Cancer among Norwegian Women (the NOWAC Study).
    Bakken T; Braaten T; Olsen A; Kyrø C; Lund E; Skeie G
    Nutrients; 2016 Jan; 8(1):. PubMed ID: 26771634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cigarette smoking and risk of colorectal cancer among Norwegian women.
    Gram IT; Braaten T; Lund E; Le Marchand L; Weiderpass E
    Cancer Causes Control; 2009 Aug; 20(6):895-903. PubMed ID: 19274482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone therapy in relation to survival from large bowel cancer.
    Newcomb PA; Chia VM; Hampton JM; Doria-Rose VP; Trentham Dietz A
    Cancer Causes Control; 2009 May; 20(4):409-16. PubMed ID: 18998219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is breast cancer risk the same for all progestogens?
    Stute P
    Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term use of statins and risk of colorectal cancer: a population-based study.
    Singh H; Mahmud SM; Turner D; Xue L; Demers AA; Bernstein CN
    Am J Gastroenterol; 2009 Dec; 104(12):3015-23. PubMed ID: 19809413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study.
    Limburg PJ; Anderson KE; Johnson TW; Jacobs DR; Lazovich D; Hong CP; Nicodemus KK; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):133-7. PubMed ID: 15668486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Phosphodiesterase 5 Inhibitors Is Associated With Lower Risk of Colorectal Cancer in Men With Benign Colorectal Neoplasms.
    Huang W; Sundquist J; Sundquist K; Ji J
    Gastroenterology; 2019 Sep; 157(3):672-681.e4. PubMed ID: 31103628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical activity patterns and the risk of colorectal cancer in the Norwegian Women and Cancer study: a population-based prospective study.
    Oyeyemi SO; Braaten T; Licaj I; Lund E; Benjaminsen Borch K
    BMC Cancer; 2018 Dec; 18(1):1216. PubMed ID: 30514263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women.
    Newcomb PA; Zheng Y; Chia VM; Morimoto LM; Doria-Rose VP; Templeton A; Thibodeau SN; Potter JD
    Cancer Res; 2007 Aug; 67(15):7534-9. PubMed ID: 17671225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menopausal hormone therapies and risk of colorectal cancer: a Swedish matched-cohort study.
    Liu Q; Simin J; Debelius J; Fall K; Sadr-Azodi O; Engstrand L; Williams C; Brusselaers N
    Aliment Pharmacol Ther; 2021 Jun; 53(11):1216-1225. PubMed ID: 33857339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
    Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
    Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen plus progestin and colorectal cancer in postmenopausal women.
    Chlebowski RT; Wactawski-Wende J; Ritenbaugh C; Hubbell FA; Ascensao J; Rodabough RJ; Rosenberg CA; Taylor VM; Harris R; Chen C; Adams-Campbell LL; White E;
    N Engl J Med; 2004 Mar; 350(10):991-1004. PubMed ID: 14999111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone therapy for preventing cardiovascular disease in post-menopausal women.
    Main C; Knight B; Moxham T; Gabriel Sanchez R; Sanchez Gomez LM; Roqué i Figuls M; Bonfill Cosp X
    Cochrane Database Syst Rev; 2013 Apr; (4):CD002229. PubMed ID: 23633307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer incidence and menopausal hormone therapy in Norway from 2004 to 2009: a register-based cohort study.
    Suhrke P; Zahl PH
    Cancer Med; 2015 Aug; 4(8):1303-8. PubMed ID: 25991514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproductive and hormonal factors and mortality among women with colorectal cancer in the NIH-AARP Diet and Health Study.
    Arem H; Park Y; Felix AS; Zervoudakis A; Brinton LA; Matthews CE; Gunter MJ
    Br J Cancer; 2015 Jul; 113(3):562-8. PubMed ID: 26103572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian cancer risk in postmenopausal women using estradiol-progestin therapy - a nationwide study.
    Koskela-Niska V; Lyytinen H; Riska A; Pukkala E; Ylikorkala O
    Climacteric; 2013 Feb; 16(1):48-53. PubMed ID: 22640598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmenopausal hormone therapy and breast cancer risk: the Multiethnic Cohort.
    Lee S; Kolonel L; Wilkens L; Wan P; Henderson B; Pike M
    Int J Cancer; 2006 Mar; 118(5):1285-91. PubMed ID: 16170777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal cancer in women: hormone replacement therapy and chemoprevention.
    Barnes EL; Long MD
    Climacteric; 2012 Jun; 15(3):250-5. PubMed ID: 22612611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective study of menopausal hormones and risk of colorectal cancer (United States).
    Troisi R; Schairer C; Chow WH; Schatzkin A; Brinton LA; Fraumeni JF
    Cancer Causes Control; 1997 Mar; 8(2):130-8. PubMed ID: 9134236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.